What is Daypro?
Daypro is a prescription non-steroidal anti-inflammatory drug (NSAID) used to treat pain or inflammation caused by arthritis. This medicine works by blocking the effects of special enzymes that play a key role in making prostaglandins. By blocking these enzymes, Daypro stops the body from making as many prostaglandins. This means less swelling and less pain.
Daypro is manufactured and marketed by Pfizer Inc. and was approved by the U.S. Food and Drug Administration (FDA) in January 1993.
What's the Problem?
Daypro and other NSAID pain relievers can trigger dangerous autoimmune reactions in which the body’s own immune system treats its own tissue as a foreign invader.
In its first year on the market, Daypro was implicated in at least 4 deaths. Between 1993 and 1997, Daypro was linked to more adverse skin reaction deaths than any other prescription NSAID available.
Related Article: Stevens-Johnson Syndrome Lawsuit Update
What is Stevens-Johnson Syndrome?
In Stevens-Johnson syndrome (SJS), the body attacks its own skin. The condition's first symptoms typically include a mild fever, which doctors may initially misdiagnose as the flu.
However, SJS rapidly progresses to a painful rash with sores and ulcers. In some cases, the reaction spreads to the eyes and internal organs.
The scarring from Stevens-Johnson syndrome can leave a person permanently disfigured or disabled. In cases in which the damage spreads to the eyes or internal organs, complications of SJS may leave patients permanently blind or with reduced organ function. Unfortunately, about 10% of patients who develop SJS die from the disease.
Stevens-Johnson Syndrome Symptoms
- Flu-like symptoms
- High temperature
- Sore throat
- Joint pain
- Rash usually starts on the upper body before quickly spreading to the face, arms, legs, and other areas of the body, such as the genitals.
What is Toxic Epidermal Necrolysis?
The most extreme cases of Stevens-Johnson Syndrome progress to a more severe form of the disease known as Toxic Epidermal Necrolysis (TEN). In patients with TEN, patches of the skin die and slough off, with the skin damage being so bad that it resembles thermal burns. In fact, TEN is often treated in hospital burn wards, since the damage is so similar. The mortality rate for Toxic Epidermal Necrolysis is nearly 50%.
Daypro and Women
According to eHealthMe, at least 1,904 patients reported side effects from Daypro, and of those, 22 had Stevens-Johnson syndrome. SJS is very rare - only about 300 cases of the disease are diagnosed in the U.S. each year, with most of these cases (<80%) occurring in women.
Is There an SJS Warning on the Daypro Label?
Due to the rarity of Stevens-Johnson syndrome, few manufacturers warn about the risk of the illness on their products' labeling. DayPro, like many popular medications, does not include SJS on its label warnings.
What are SJS Lawsuits Alleging?
Plaintiffs in Stevens-Johnson syndrome lawsuits allege that drug manufacturers were aware of the health risks associated with their products, but failed to inform the public and medical communities. Although the risk of SJS is small, it is still present, so an investigation has been initiated to see if there is a potential lawsuit against the makers of Daypro and other medications linked to SJS and TEN.
See all related dangerous drug lawsuits our attorneys covered so far
Get a Free Daypro Stevens-Johnson Syndrome Lawsuit Evaluation With Our Lawyers
The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Daypro Stevens-Johnson Syndrome lawsuits. We are handling individual litigation nationwide and currently investigating potential settlements in all 50 states.
Again, if you or a loved one was diagnosed with Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) after taking Daypro, you should contact our law firm immediately for a free case review. You may be entitled to compensation by filing a suit for legal fees and our defective drug lawyers can help with a free case evaluation.